FDA Approves First Canine Cancer Therapy
Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved the first canine cancer therapy in the U.S. - PALLADIATM (toceranib phosphate) - which was developed by Pfizer to treat mast cell tumors in dogs. Pfizer made the announcement to veterinarians attending the 2009 American College of Veterinary Internal Medicine (ACVIM) Forum and Canadian Veterinary Medical Association Convention.
read more
print page
Deceases & treatment
- Specific immunotherapy (xenovaccinotherapy) for cancer
- T-cell vaccination (autovaccinotherapy) for autoimmune diseases
- Regenarative therapy
- Clinical application of stem celltransplantation
- Cell transplantation (CT) in treating severe neurological disorders (general information)
- Hepatic diseases
- Osteomielitis
- Arthrosis
